Abstract
When dealing with a patient who has a chronic or a life-threatening illness, physical illness receives utmost care but psychosomatic aspect very little. Thus, we speak of the “coronary” needing intensive care and the “psychosomatic” needing psychotherapy which in fact is responding to one part of the problem. The patient who suffers from a disease is neither psyche nor soma alone and will be grateful to you if he will derive benefit from a comprehensive therapy. The origin, perpetuation and treatment of psychosomatic illnesses are multifaceted. Focusing on one aspect of the problem to the exclusion of others is definitely not beneficial. I address myself primarily to the usefulness of psychoactive drugs in some of the physical disorders not to imply its exclusive value but to expose its synergestic value with other forms of therapy. In addition, the opposite problem, rather more serious, psychosomatic disorders secondary to psychoactive drug therapy will also be elucidated to impart the feeling that art of using the medication in the total treatment regime and not mere application is important.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adler, R.H.: Psychotropic agents in the management of chronic pain. J. Human Stress 4; 13–17, 1978.
Ananth, J.: Antiasthmatic effects of chrlorpromazine. Canad. Med. Assoc. J. 110; 1131, 1974.
Ananth, J. and Huapaya, L.: Depression associated with hypertension: a review. Psychiat. J. Univ. Ottawa 5; 58–62, 1980.
Bradley, J.J.: Severe localized pain associated with the depressive syndrome. Brit. J. Psychiat. 109; 741–745, 1963.
Chevenne, J.: Treatment of pain with a group of phenothiazine amines. La Presse Medicale 68; 2347-, 1960.
Couch, J.R., Zeigler, D.K. and Hassanein, R.: Amitriptyline in the prophylaxis of migraine. Neurology 26; 121–127, 1976.
Crocket, J.A.: Chlorpromazine in asthma, chronic bronchitis and emphysema. Brit. J. Tuberculosis Dis. Chest 50; 221–224, 1956.
Csatary, L.K.: Cancer and chlorpromazine. Lancet. 2; 338–339, 1972.
Dabbs, C.H. and Peirce, E.C.: Causalgiz treated with chlorpromazine hydrochloride. J.A.M.A. 159; 1626–1628, 1955.
Freyhan, F.A.: Loss of ejaculation during mellaril treatment. Amer. J. Psychiat. 118; 171–172, 1961.
Friedman, A.P.: The migraine syndrome. Bull. N.Y. Acad. Med. 44; 45–62, 1968.
Gardos, G. and Cole, J.O.: Weight reduction in schizophrenics by molindone. Amer. J. Psychiat. 134; 302–304, 1977.
Goldfarb, A.A. and Venutolo, F.: The use of an antidepressant drug in chronically allergic individuals. Ann. Allergy 21; 667676, 1963.
Gomersall, J.D. and Stuart, A.: Amitriplyline in migraine prophylaxis. J. Neurol. Neurosurg. Psychiat. 36; 684–690, 1973.
Gordon, R.A. and Campbell, M.: The use of chlorpromazine in intractable pain associated with terminal carcinoma. Canad. Med. Assoc. J. 75; 420–421, 1956.
Greer, S., Morris, T. and Pettingale, K.W.: Psychological response to breast cancer: effect on outcome. Lancet. 2; 785–787, 1979.
Guy, R.: An essay on scirrous tumours and cancer. J & A Churchill: London, 1959.
Hart, F.D.: The use of psychotropic drugs in rheumatology. J. Int. Med. Res. 4; 15–19, 1976.
Heller, J.: Another case of inhibition of ejaculation as side effect of mellaril. Amer. J. Psychiat. 118; 173–174, 1961.
Hill, R., Bell, C., Goldberg, H.: Effect of fluphenazine hydrochloride on R3230 A.C. mammary carcinoma and mammary glands of the rat. Cancer Res. 31; 1111–1127, 1971.
Katz, J., Kunofsky, S., Patton, R.E.: Cancer mortality among patients in New York mental hospitals. Cancer 20; 2194–2199, 1967.
Kerr, T.A., Schapira, K. and Roth, M.: The relationship between premature death and affective disorder. Brit. J. Psychiat. 115; 1277–1282, 1969.
Lance, J.W. and Curran, D.A.: Treatment of chronic tension headache. Lancet 2; 1236–1239, 1964.
Lasagna, L. and DeKornfeld, T.J.: Methotrimeprazine: a new phenothiazine derivative with analgestic properties. J.A.M.A. 178; 887–888, 1961.
Lassman, P.L., Moody, J.F. and Gryspeerdt, G.L.: Central pain due to cerebral ischaemia. folia psychiatrica neurologica, et Neuroschiriargica Needlandica 62; 34–1959.
Lee, R. and Spencer, P.S.J.: Antidepressants and pain: a review of the pharmacological data supporting the use of certain tricyclics in chronic pain. J. Inter. Med. Res. 5; 146–156, 1977.
Lesse, S.: Masked depression–a diagnostic and therapeutic problem. Dis. Nerv. Syst. 29; 169–173, 1968.
Levij, I.S. and Polliak, A.: Inhibitions of chemical carcinogenesis in the hamster cheek pouch by topical chlorpromazine. Nature 228; 1096–1097, 1970.
Lindsay, P.G. and Wyckoff, M.: The depression pain syndrome and its response to antidepressants. Psychosomatics 22; 571–577, 1981.
Mahloudji, M.: Prevention of migraine. Brit. Med. J. 1; 182–183, 1969.
Mearles, R.A., Mills, J.E., Horvath, T.B., Atkinson, J.M., Pun, L.Q. and Rand, M.J.: Amitriptyline and asthma. Med. J. Aust. 2; 25–28, 1971.
Merskey, H.:• Psychiatric patients with persistent pain. J. Psychosom. Res. 10; 383–387, 1967.
Merskey, H. and Hester, R.A.: The treatment of chronic pain with psychotropic drugs. Postgrad. Med. J. 48; 594–598, 1972.
Montilla, E., Frederick, W.S. and Cass, L.J.: Analgesic effect of methotrimeprazine and morphine: a clinical comparison. Arch. Int. Med. 111; 725, 1963.
Panaccio, V.: Trimeprazine: a new phenothiazine derivative for treatment of pruritic dermatoses. Canad. Med. Assoc. J. 80; 885–1959.
Paoli, R., Darcourt, G. and Cossa, P.: Preliminary note on the action of imipramine in painful states. Rev. Neurol. 102; 503–1960.
Paradis, B.: Analgesic and anaesthitic properties of levomepromazine (NO2INAN–7044RP). Canad. Anaesthetists Soc. J. 9; 153–1962.
Pilowsky, I., Chapman, C.R. and Bonica, J.J.: Pain, depression and illness behavior in a pain clinic population. Pain 4; 183191, 1977.
Pisciotta, A.V.: Agronulocytosis induced by certain phenothiazine derivaties. J.A.M.A. 208; 1862–1868, 1969.
Pudov, V.I.: Effect of aminazine on metastatic dissemination of Brown-Pearce tumour. Farmikol Toksikol. 34; 454–456, 1971.
Rassidakis, N.C., Kelleporis, M. and Fox, S.: Malignant neoplasma as a cause of death among psychiatric patients. Int. Ment. Health Res. Newsletter 13; 6, 1971. •
Rassidakis, N.C., Kelleporis, M. and Karaiassefidis, K.: Malignant neoplasm as a cause of death among psychiatric patients. Int. Mental Health Res. Newsletter 14; 1–3, 1972.
Robinson, K.C., Zuck, D.: Chlorpromazine in status asthmaticus. Lancet 1; 1349, 1954.
Sanger, M.D.: Psychosomatic allergy. Psychosomatics 11; 473–476, 1970.
Scott, W.A.M.: The relief of pain with an antidepressant in arthritis. Practioner 202; 802–807, 1969.
Shader, R.I.: Sexual dysfunction associated with thioridazine hydrochloride. J.A.M.A. 188; 1007–1009, 1964.
Shader, R.I., Nahun, J.P. and DiMascio A.: Amenorrhea in psycho-tropic drug side effects. (Ed) R.I. Shaker & A. DiMascio, Baltimore, Williams & Wilkins, 1970.
Sigwald, J., Bouttier, D. and Caille, F.: The treatment of herpes and post-herpetic pain. Study of the results obtained with levomepromazine. Therapie 14; 818–1959.
Sigwald, J., Herbert H. and Quetin A.: The treatment of herpes and post-herpetic pain with phenothiazine derivatives. Semaine des hopitaux de Paris 33; 1137–1957.
Singh, G. and Verma, H.C.: Drug treatment of chronic intractable pain in patients referred to a psychiatry clinic. J. Indian Med. Ass. 56; 341–345, 1971.
Singh, H.: Case of inhibition of ejaculation as side effect of mellaril. Amer. J. Psychiat. 117; 1041–1042, 1961.
Snow, H.: Cancer and cancer process. J & A Churchill: London, 1893.
Spear, F.G.: Pain in psychiatric patients. J. Psychosom. Res. 11; 187–193, 1967.
Sternbach, R.A., Janowski, D.S., Huey, L.Y.: Effects of altering brain serotonin activity on human chronic pain. In Bonica J.J. (ed): Advances in pain research and therapy. New York. Raven Press. 1976. Vol. 1, pp. 601–606.
Sughihara, H., Ishiara, K. and Noguchi, H.: Clinical experience with amitriptyline (tryptonol) in the treatment of bronchial asthma. Ann. Allergy 23; 422–1965.
Surawicz, F.G., Brightwell, D.R., Weitzel, D.W. and Ekkehard, O.: Cancer, emotions and mental illness: the present state of understanding. Amer. J. Psychiat. 133; 1306–1309, 1976.
Taub, A.: Relief of postherpetic neurolgia with psychotropic drugs. J. Neurosurg. 39; 235–239, 1973.
Taubel, D.E.: Mellaril: Ejaculation disorders. Amer. J. Psychiat. 119; 87–1962.
Taylor, D.C.: The components of sickness: diseases, illnesses and predicaments. Lancet 2; 1008–1010, 1979.
Tyber, M.A.: Treatment of painful shoulder syndrome with amitriptyline and lithium carbonate. Canad. Med. Assoc. J. 111; 137140, 1974.
Varsamis, J., Zuckhowski, T. and Maini, K.K.: Survival rates of death in geriatric psychiatric patients: a six year follow-up. Canad. Psychiat. Assoc. J. 7; 17–22, 1972.
Von Knorring, L.: The experience of pain in depressed patients. Neuropsychobiology 1; 155–165, 1975.
Ward, N.G., Bloom, V.L. and Friedel, R.O.: The effectiveness of tricyclic antidepressants in the treatment of co-existing pain and depression. Pain 7; 331–341, 1979.
Watson, C.G. and Schuld, D.: Psychosomatic factors in the etiology of neoplasms. J. Consultative and Clinical Psycholosy 45; 455–464, 1977.
Webb. H.E. and Larscelles, R.G.: Treatment of facial and head pain associated with depression. Lancet 1; 355–356, 1962.
Whitlock, F.A. and Siskind, M.: Depression and cancer: a followup study. Psychol. Med. 9; 747–752, 1979.
Wilson, R.C.D.: Antiasthmatic effect of amitriptyline. Canad. Med. Assoc. J. 111; 212, 1974.
Woodforde, J.M., Dwyer, B., McEwen, B.W.: Treatment of postherpetic neurolgia. Med. J. Australia 2; 869–872, 1965.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Ananth, J. (1983). Psychoactive Drugs in Psychosomatic Medicine. In: Krakowski, A.J., Kimball, C.P. (eds) Psychosomatic Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4496-4_88
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4496-4_88
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4498-8
Online ISBN: 978-1-4684-4496-4
eBook Packages: Springer Book Archive